Growth Investing: Paying for Duration
Growth investing means buying businesses expected to grow earnings much faster than average and paying a higher price for that expectation. The return does not come from the growth itself, which the price already reflects, but from that growth lasting longer than the market assumed.
How it works
The method is a single exchange, made deliberately. You identify a business whose earnings or cash flow should grow substantially faster than average, and you accept a higher price today in return for that expected growth. The security you end up holding is a growth stock.
The arithmetic behind that exchange is sound. A business compounding faster is genuinely worth more per dollar of current earnings, and any honest valuation method — a discounted cash flow among them — will say so.
But only if it lasts longer than the market thinks. A high growth rate is already in the price; the return comes from the growth persisting beyond the period the price assumes, not from the growth itself.
So the price contains two assumptions, not one. A rate, and a number of years that rate holds for. The rate is the one everybody argues about; the duration is the one that decides the outcome.
Fade, and what it does to a portfolio
And almost every high growth rate fades. Competition arrives, the base gets larger, and growing from a big number is harder than growing from a small one. A valuation that assumes a high rate indefinitely is assuming something that has rarely happened.
Which makes the real question defensive rather than optimistic. What stops a competitor taking the growth — a structural cost advantage, switching costs, a network effect, a regulatory position — and how many years can that hold?
The second question is what the retained earnings earn. A growing business keeps its profits rather than paying them out, so the return on that reinvested capital is what actually compounds. Revenue can rise for years on capital that earns poorly, which looks like success while destroying value.
A few winners carry the whole portfolio. Most holdings fade roughly on schedule and a small number do not, so concentration is a feature of the approach rather than a choice within it. This is the part Peter Lynch is most often associated with, and the dispersion of results is wide.
So the drawdowns are deeper than people expect. A share whose value sits in distant profits reprices sharply when expectations about those profits change, and that happens without anything occurring at the company at all.
In practice
Most people buy this method through a fund, and growth funds are actively managed. Compounding the annual charge alone over thirty years, 5 basis points removes 1.5% of the pot, 20 removes 5.8%, 75 removes 20.2% and 150 removes 36.5%. A basis point is one hundredth of a percentage point.
Volume tends to peak with the story rather than with the business. Interest is loudest when the growth is most widely believed, which is also when the price already contains the most optimism about it.
The horizon has to be genuine. Duration is the thing being bought, so a year of results says nothing about whether you bought it correctly; a decade is the shortest period over which the question can be answered.
The re-rating happens on earnings night. One sentence of guidance can shorten the assumed duration, and the price gaps to the new assumption before anyone can act on it.
And there is no stop in the approach. A falling price is not evidence about the growth rate, so an automatic exit at a level would sell the position for a reason the method does not recognize.
Which makes the exit a judgment rather than a rule. You sell when the thing protecting the growth breaks, or when the duration you paid for has visibly shortened — not when the chart does something.
Dealing costs barely matter here, which is the one easy part. Buying and selling a $100 stock quoted with a 5-cent spread costs 0.05% of the position in spread — trivial against a holding period measured in years.
Working backwards from the price
The useful check runs the valuation backwards. Rather than forecasting a growth rate and producing a price, take the price you are being asked to pay and solve for the rate and the number of years it implies.
Then leave the arithmetic and ask an industry question. What would have to be true for that rate to hold for that long — how large would the business have to become, how much of its market would it need, and who would have to fail to respond?
The answer is often uncomfortable in a specific and useful way. A price can quietly require a business to grow past the size of the market it serves, or to hold a margin no competitor ever erodes.
That is the whole value of the exercise: it turns an opinion into a claim you can examine. Intrinsic value is not a figure you look up. It is the set of assumptions you are prepared to defend out loud.
What growth investing is not
It is not buying whatever has already risen. Price momentum is not a growth rate.
It is not the opposite of value investing. Both estimate what a business is worth.
It is not indifferent to price. An excellent business can still be too dear.
And it is not a shorter route. It is judged over a decade like everything else.
How this connects
Margin quality tells you whether the growth can pay. A rising gross margin and an operating margin that widens with scale suggest the growth will eventually produce profit, while heavy research and development spending is often the investment that protects it.
It is often confused with momentum trading. A momentum stock is chosen for how its price has behaved; a growth investor is buying a business forecast, and the two only overlap when the story is popular.
Factor investing treats growth as one exposure among several, and many growth portfolios are also tilted toward small cap names and high market beta, which explains much of their volatility.
The typical index expression is technology-heavy. An NDX tracker or a growth-labeled ETF gives the style broadly, with a lower expense ratio than a fund manager picking names, which is the case for passive investing here.
Concentration risk is the cost of the approach, and a sector ETF built on a theme adds it without the business analysis.
The contrast with income is structural. Growth companies rarely offer a meaningful dividend yield, so the investor’s time horizon and risk tolerance have to accept years with nothing but price.
The skeptics are worth reading. Warren Buffett and Howard Marks both argue that a great company can be a poor purchase at the wrong price, and the meme stock episodes show what happens when story replaces the numbers.
And buy and hold is the only holding pattern the method really fits.
When it fails
In a flat market the multiple does the damage. A share held at a high price relative to current earnings has further to fall than one held at a low price, and a long trading range grinds through the patience the method requires.
The commonest failure is paying for a duration nobody could deliver. The business grows, the growth is real, and the return is still poor because the price assumed more years of it than arrived.
A second is mistaking revenue growth for value creation. Capital retained at a poor return compounds against the owner while the top line keeps rising and the story keeps working.
A third is diversifying the concentration away. Holding enough names to smooth the dispersion also removes the few positions meant to carry the result, at which point index funds do the same job far more cheaply.
A fourth is selling on price rather than on thesis. A deep fall is the ordinary condition of a long-duration holding, and exiting into one converts a repricing into a realized loss.
And a fifth is buying the story late. By the time the growth is widely agreed, the duration is fully priced and there is very little left to be paid for.
The original data
The scan behind this page ran over the 24,971 videos collected for this site’s search study. “Growth investing” appears in 19 titles across 18 channels at a median of 573 views and a maximum of 113,873 — one of the lowest medians recorded for any investing term here, against 78 videos and a 13,135 median for “value investing” across 52 channels. What people actually watch is individual growth stocks: 112 videos, 87 channels, median 4,172. The discipline behind choosing them has the smaller audience.
The question: Growth slowing, price still high. Hold?
Then the fee arithmetic, which compounds the annual charge alone with no return assumption. Growth funds are typically actively managed and priced accordingly, and at 75 basis points a year the charge alone removes 20.2% of a thirty-year pot before any question of stock selection arises. The vehicle’s cost is certain; the manager’s skill is not. State the number of years of above-average growth the current price requires, and name what protects it for that long — if you cannot name the protection, you are paying for a rate with nothing behind it.
Related
Growth stock is the security this method buys, and what to look for in one. Valuation is where the implied rate and the implied duration actually come from. And value investing runs the same arithmetic from the other end.
I do not treat a fast growth rate as the reason to buy, because the price has usually accounted for it already. Ask how many years of that growth the price is quietly assuming, and whether anything about the business makes that plausible. I name the thing protecting the growth before I look at the multiple at all, and if I cannot name it in a sentence I am guessing about the part that decides the outcome.
— Michael Whitman
This page is educational, not financial advice. Test every idea on your own charts before risking money.